Showing 10 of 108081 citations.
A44. COVID AND ITS CONSEQUENCES: PART I | May 1, 2023 | Volume: No volume available | Issue: No issue available | Pages: A1641-A1641
A44. COVID AND ITS CONSEQUENCES: PART I | May 1, 2023 | Volume: No volume available | Issue: No issue available | Pages: A1640-A1640
A44. COVID AND ITS CONSEQUENCES: PART I | May 1, 2023 | Volume: No volume available | Issue: No issue available | Pages: A1620-A1620
A41. EMERGING CLINICAL AND TRANSLATIONAL RESEARCH IN COPD AND ALPHA-1-ANTITRYPSIN | May 1, 2023 | Volume: No volume available | Issue: No issue available | Pages: A1566-A1566
D19. NEW PERSPECTIVES ON TRANSLATIONAL STUDIES FOR LUNG FIBROSIS | May 1, 2023 | Volume: No volume available | Issue: No issue available | Pages: A6260-A6260
D28. HOW CAN WE DO BETTER: EMERGING DIAGNOSTICS AND THERAPEUTICS IN PULMONARY VASCULAR DISEASE | May 1, 2023 | Volume: No volume available | Issue: No issue available | Pages: A6453-A6453
C21. "CUTTING" EDGE: CLINICAL STUDIES IN INTERVENTIONAL PULMONARY AND PLEURAL DISEASE | May 1, 2023 | Volume: No volume available | Issue: No issue available | Pages: A4538-A4538
D21. TRANSLATIONAL COVID-19 STUDIES | May 1, 2023 | Volume: No volume available | Issue: No issue available | Pages: A6299-A6299
D21. TRANSLATIONAL COVID-19 STUDIES | May 1, 2023 | Volume: No volume available | Issue: No issue available | Pages: A6286-A6286
B22. NEW TREATMENTS AND NOVEL TARGETS FOR COPD AND ALPHA-1 | May 1, 2023 | Volume: No volume available | Issue: No issue available | Pages: A2858-A2858